Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|6|850-860

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.6, 2012-02, pp. : 850-860

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events

By Ling Geoffrey  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 3, 2009-05 ,pp. : 197-209

Adis International

Access to resources Recommend Favorite

Antiplatelet therapy in secondary stroke prevention

By Crawford K Michelle   Talbert Robert L  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1609-1613

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet Agents for the Prevention of Cardiovascular Disease in Diabetes Mellitus

By Colwell John A.  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 87-106

Adis International

Access to resources Recommend Favorite

Primary and Secondary Stroke Prevention with Antiplatelet Drugs

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1293-1297

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet therapy for the primary prevention of pre-eclampsia

By  

Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite